38 research outputs found

    Supplemental_table_1 – Supplemental material for Habit strength as a moderator of the association between symptoms of poor mental health and unintentional non-adherence to oral hypoglycemic medication in adults with type 2 diabetes

    No full text
    Supplemental material, Supplemental_table_1 for Habit strength as a moderator of the association between symptoms of poor mental health and unintentional non-adherence to oral hypoglycemic medication in adults with type 2 diabetes by Rachel J Burns, Sonya S Deschênes, Bärbel Knäuper and Norbert Schmitz in Journal of Health Psychology</p

    Kaplan-Meier Survival Curves stratified by depression-cardiometabolic groupings.

    No full text
    <p>DCM: comorbid high depressive symptoms and cardiometabolic abnormalities group; DnoCM: high depressive symptoms only group; noDCM: cardiometabolic abnormalities only group; noDnoCM: no or low depressive symptoms and no cardiometabolic abnormalities group.</p

    Hazard Ratios (95% CI) of diabetes across depression-cardiometabolic groupings using multiple imputation by chained equations.

    No full text
    Hazard Ratios (95% CI) of diabetes across depression-cardiometabolic groupings using multiple imputation by chained equations.</p

    Diabetes distress, depressive symptoms, and anxiety symptoms in people with type 2 diabetes: A network analysis approach to understanding comorbidity

    No full text
       Objective This study aimed to explore interactions between individual items assessing diabetes distress, depressive symptoms, and anxiety symptoms in a cohort of adults with type 2 diabetes using network analysis. Research design and methods Participants (N = 1,796) were from the Evaluation of Diabetes Insulin Treatment (EDIT) study from Quebec, Canada. A network of diabetes distress was estimated using the 17 items of the Diabetes Distress Scale (DDS-17). A second network was estimated using the 17 DDS-17 items, the 9 items of the Patient Health Questionnaire, and the 7 items of the Generalized Anxiety Disorder Assessment. Network analysis was used to identify central items, clusters of items, and items that may act as bridges between diabetes distress, depressive symptoms, and anxiety symptoms.  Results Regimen-related and physician-related problems were amongst the most central (highly connected) and influential (most positive connections) in the diabetes distress network. Failure (depressive symptom) was found to be a potential bridge between depression and diabetes distress, being highly connected to diabetes distress items. The anxiety symptoms of worrying too much, uncontrollable worry, and trouble relaxing were identified as bridges linking both anxiety and depressive items, and anxiety and diabetes distress items, respectively. Conclusions Regimen-related and physician-related diabetes-specific problems may be important in contributing to the development and maintenance of diabetes distress. Feelings of failure and worry are potentially strong candidates for explaining comorbidity. These individual diabetes-specific problems and mental health symptoms could hold promise for targeted interventions for people with type 2 diabetes.</p

    sj-docx-1-hpq-10.1177_13591053241243285 – Supplemental material for Childhood maltreatment and the risk of impaired glucose metabolism or type 2 diabetes in young adults: Findings from the Lifelines Cohort Study

    No full text
    Supplemental material, sj-docx-1-hpq-10.1177_13591053241243285 for Childhood maltreatment and the risk of impaired glucose metabolism or type 2 diabetes in young adults: Findings from the Lifelines Cohort Study by Sonya S. Deschênes, Finiki Nearchou, Amy McInerney, Norbert Schmitz, Frans Pouwer and Arie Nouwen in Journal of Health Psychology</p

    Participant Flow Chart.

    No full text
    <p>DCM: comorbid high depressive symptoms and cardiometabolic abnormalities group; DnoCM: high depressive symptoms only group; noDCM: cardiometabolic abnormalities only group; noDnoCM: no or low depressive symptoms and no cardiometabolic abnormalities group; ELSA: English Longitudinal Study of Ageing.</p

    Association between Depressive Symptoms and Cognitive Function in Persons with Diabetes Mellitus: A Systematic Review

    No full text
    <div><p>Depression and diabetes are independent risk factors for one another, and both are associated with increased risk of cognitive decline. Diabetes patients with lower cognitive function are more likely to suffer poorer health outcomes. However, the role of depression in cognitive decline among people with diabetes is not well understood. This systematic review assessed whether adults with comorbid diabetes and depression or depressive symptoms exhibit greater cognitive decline relative to individuals with diabetes alone. Searches were run in CINAHL, the Cochrane Central Register of Controlled Trials, EMBASE, PsycINFO, and PubMed (MEDLINE) with no time or language restrictions. Studies were eligible for inclusion if they were of any quantitative study design, included participants aged 18 years or older with diabetes mellitus of which some must have presented with current depression, and measured cognition as an outcome. The Cochrane Collaboration’s Risk Of Bias In Non-randomized Studies–of Interventions tool was used for quality assessment of each study and its collected outcome. Fifteen articles were included in the final analysis. The high degree of heterogeneity in exposures, outcomes, and participant characteristics precluded a meta-analysis of any of the studies, and the risk of bias observed in these studies limits the strength of the evidence. Nonetheless, this review found the presence of comorbid depression was associated with poorer cognitive outcomes than for persons with diabetes alone. While large-scale preventive efforts must address epidemic levels of diabetes and its comorbidities, on the patient level healthcare professionals must be cognizant of the added difficulties that depression poses to patients and the extra support required to management diabetes in these cases. This systematic review is registered with the University of York Centre for Reviews and Dissemination under registration number 2015:CRD42015025122.</p></div
    corecore